Acute severe thrombocytopenia after treatment with ReoPro (abciximab).

Abstract

ReoPro (abciximab) is an extremely potent inhibitor of the glycoprotein IIb/IIIa receptor, the final common pathway of platelet activation and aggregation. Its main role is the maintenance of coronary patency after suboptimal results with coronary intervention. However, one of the complications of this treatment is excessive bleeding, a problem which may be… (More)

Topics

Cite this paper

@article{Butler2000AcuteST, title={Acute severe thrombocytopenia after treatment with ReoPro (abciximab).}, author={R. Butler and Pia Hubner}, journal={Heart}, year={2000}, volume={83 4}, pages={E5} }